MDAI Stock Analysis: Buy, Sell, or Hold?
MDAI - Spectral AI, Inc. Class A Common Stock
$2.19
0.14 (6.83%)
▲
5d:
+19.02%
30d:
+52.08%
90d:
+25.14%
HOLD
MODERATE Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 13, 2026
11d
Get Alerted When MDAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: MDAI is 12.3% above its trading range ($1.95). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: MDAI is 12.3% above its trading range ($1.95). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: MDAI is currently trading at $2.19, which is considered extended relative to its 30-day fair value range of $1.56 to $1.95.
Technical Outlook: Technically, MDAI is in a uptrend. The price is approaching resistance at $2.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: MDAI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.67 (+127.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MDAI is in a uptrend. The price is approaching resistance at $2.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: MDAI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.67 (+127.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.56 -
$1.95
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+12.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 127.6% below Wall St target ($4.67)
Trading Range Analysis
30-Day Trading Range
$1.56 -
$1.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.73
Resistance Level
$2.19
Current Trend
Uptrend
Technical data as of
May 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.77
Wall Street Target
$4.67
(+127.6%)
Revenue Growth (YoY)
-46.3%
Profit Margin
-38.5%
Share & Embed Analysis
Last updated: May 01, 2026 3:15 PM ET
Data refreshes hourly during market hours. Next update: 4:15 PM
Data refreshes hourly during market hours. Next update: 4:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$87 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$419 | 42 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 54 HOLD |